BIOQUAL, Inc.
  • Home
  • About Us
  • Research Services
    • COVID-19
    • AIDS
    • Zika
    • Influenza
    • RSV
    • Malaria
    • Other Infectious Disease Areas
  • Financials / Press Releases
  • Contact Us
    • Get Quote
    • Jobs
Select Page

COVID-19

Animal Models

  • Golden Syrian hamsters
  • BALB/c mice
  • hACE2 tg mice
  • Ferrets
  • Rhesus and cynomolgus macaques

Study Types

  • Vaccine testing
  • Therapeutics testing
  • PK/safety testing
  • Pathogenesis

In vitro Services

  • Sample processing
  • RT-PCR and plaque assay viral load testing
  • Binding antibody ELISA and PRNT

Representative Publications

Correlates of protection against SARS-CoV-2 in rhesus macaques

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice

REGN-COV2 Antibodies Prevent and Treat SARS-CoV-2 Infection in Rhesus Macaques and Hamsters

Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters

Potently neutralizing and protective human antibodies against SARS-CoV-2

SARS-CoV-2 infection protects against rechallenge in rhesus macaques

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

BIOQUAL involved in the fight against COVID-19

BIOQUAL, Inc.

Partnering with government, academic, and commercial organizations to provide innovative research support for improved global health



240-404-7654

800-208-3149



info@bioqual.com



BIOQUAL, Inc.
9600 Medical Center Drive
Suite 101
Rockville, MD 20850-3336

Copyright © 2021, BIOQUAL, Inc. All Rights Reserved. Website Design by Studio98

John C. Landon, founder of BIOQUAL, Inc., passes away at the age of 84.

Dr. John C. Landon, past president, CEO and former chairman of the board of BIOQUAL, passed away Sunday, January 10, 2021 at the age of 84. John was born and raised in Hornell, New York, and went on to earn a B.A. degree in biology from Alfred College class of 1959 and a M.S. and Ph.D. in biology from The George Washington University in 1962 and 1967, respectively. John worked for most of his career in Maryland, but spent his summers in Brewster, Massachusetts where he retired to in 2013.

John had a long and distinguished career in biology. He began his career at the National Cancer Institute working in cancer virology, then went on to join Litton Bionetics from 1965 until 1975, where he became the Science Director of the Frederick Cancer Research Center. In 1975, he became President and Director of Mason Research Institute, a subsidiary of EG&G now known as Perkin Elmer. In 1982,he founded BIOQUAL, a biomedical research corporation that provided contract services to the National Institutes of Health as its major client. He led BIOQUAL for more than 30 years as President and CEO, growing it from a one contract company to a $20M + life sciences corporation by the time of his retirement. BIOQUAL continues to thrive today with five facilities and has played a key role in testing vaccines and therapeutics for COVID-19 and many other infectious diseases.